Subscribe

News By Topic / News By Location / Baylor Research Institute

Baylor Research Institute

Researchers Develop Web 2.0 Apps To Share Vaccine Study

04/18/2013 In a manuscript published today in Immunity, scientists at the Baylor Institute for Immunology Research (BIIR) and the Benaroya Research Institute at Virginia Mason report the results of a comparative study...Read More »

Ultragenyx Announces In-Licensing of Clinical-Stage Product From Baylor Research Institute

01/21/2013 Ultragenyx Pharmaceutical Inc., a biotechnology company focused on the development of treatments for rare and ultra-rare genetic disorders, announced Jan. 10 that it has in-licensed rights for triheptanoin, a promising treatment for long...Read More »

Department of Education Grant Supports Traumatic Brain Injury Rehabilitation Research At Baylor Institute for Rehabilitation in Dallas

10/26/2012 Baylor Institute for Rehabilitation (BIR) has received a $2.2 million grant extending for another five years the institute’s designation as a National Institute on Disability and Rehabilitation Research Model System site for traumatic brain injury.Read More »

On The Frontlines: The Role Nurses Play in Medical Research

09/27/2012 After witnessing firsthand the lack of patient education, awareness and understanding of patients’ medical conditions - and how that affected them post-discharge, often triggering readmission - Jessica Saucier, clinical transplant rese...Read More »

Fort Worth-Based Galderma Laboratories Pledges Additional $450,000 for Dermatology Program

08/07/2012 Galderma Laboratories, L.P., part of a global pharmaceutical company exclusively focused on dermatology, has pledged $450,000 to help support the dermatology residency program at Baylor University Medical Center at Dallas. The pledge bri...Read More »

Baylor Research Institute to study ICU delirium

08/06/2012 Delirium is a potentially life threatening disturbance in brain function that frequently occurs in critically ill patients. Baylor Research Institute has received a two-year, $600,000 grant from the Agency for Healthcare Research and Qua...Read More »

NIH Grant Funds Immune Disorder Vaccine Research

07/12/2012 SangKon Oh, PhD, associate investigator at the Baylor Institute for Immunology Research (BIIR), has received a grant to research allergen-induced immune disorders such as arthritis and asthma, as a precursor to developing vaccines. The...Read More »

Baylor Research Institute, Roche, French agencies establish strategic collaboration to develop therapeutic vaccines for chronic infectious diseases

04/13/2012 Today, Baylor Research Institute (BRI, the research arm of Baylor Health Care System in Dallas), Roche, the French National Agency for Research on AIDS and Viral Hepatitis (ANRS), and Inserm Transfert announced a long-term collaboration ...Read More »

Baylor Research Institute signs international human immunology expert

04/26/2011 Baylor Research Institute (BRI), the research arm of Baylor Health Care System (BHCS), has appointed Yong-Jun Liu, M.D., Ph.D., vice president and chief scientific officer (CSO) for BRI and director of the Baylor Institute for Immunology...Read More »

Baylor Research Institute, Eureka Genomics Corporation Reach Research, Commercialization Agreement

02/23/2011 Baylor Research Institute (BRI), the research arm of Baylor Health Care System, and bioinformatics pioneer Eureka Genomics (EG) have formed a strategic alliance to achieve a better understanding of the causes of colorectal cancer, potent...Read More »

Baylor Researchers Take Step Forward in Diabetes Study

01/05/2011 Researchers at Baylor All Saints Medical Center are studying a solution they believe will improve the quantity and quality of isolated human pancreatic islet cells. The harvested cells can then be transplanted into the livers of patients...Read More »

ROCHE, Baylor Research Institute Partner in Human Immunology Research

11/16/2010 Baylor Research Institute (BRI), the research arm of Baylor Health Care System, announced today that it has formed a three-year partnership with Roche (SIX: RO, ROG; OTCQX: RHHBY) to jointly develop programs emerging from the human immu...Read More »

Dallas Researchers Join Nationwide Effort To Define Markers In Immune Responses

10/25/2010 A new nationwide research initiative has been launched to define changes in the human immune system's response to infection and vaccination using human rather than animal models, which could lead to better vaccines and other treatments. ...Read More »

Researchers Uncover Tuberculosis' Genomic Signature

09/21/2010 Dallas scientists recently discovered a molecular signature in the blood of patients with tuberculosis (TB) that may explain why some people develop an active TB infection, while others exposed to the bacteria which causes the dangerous ...Read More »

New Research Uncovers Why Many With Lupus Are Resistant To Traditional Treatments

07/09/2010 Two immune system proteins could be the culprit behind many lupus patients'' resistance to widely used steroid treatments, scientists with the Baylor Research Institute (BRI) in Dallas announced today. It is estimated that more than 5 mi...Read More »

Funding For Medical Research At Baylor Flourishes Despite A Floundering Economy

06/10/2010 Even in an economy that's proved devastating to charitable giving and government grants, the Baylor Institute of Immunology Research (BIIR), a component of Baylor Research Institute (BRI), has managed to buck the trend: BIIR received gra...Read More »

Baylor Research Institute To Collaborate With Mount Sinai School Of Medicine To Develop Therapeutic Cancer Vaccines

10/17/2007 Officials with Baylor Research Institute and the Mount Sinai School of Medicine announced today that the institutions are collaborating to develop therapeutic cancer vaccines for patients with lymphoma and myeloma, both cancers that affe...Read More »

Baylor Institute For Immunology Research Marks 10th Anniversary

09/07/2007 Baylor Institute for Immunology Research (BIIR) is celebrating its 10th anniversary this year, capping a decade of advances in understanding the immune system and developing new treatments for cancer (melanoma, breast and prostate cancer...Read More »

← View All
↑ Back to top